Company profile for Third Harmonic Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with a...
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases. Our lead product candidate, THB001, is the first highly selective, oral small-molecule KIT inhibitor to enter clinical development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
300 Technology Square, 8th Floor, Cambridge, MA 02139
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/12/3098283/0/en/Third-Harmonic-Bio-Announces-Stockholder-Approval-of-Plan-of-Liquidation-and-Dissolution-Updated-THB335-Phase-1-Clinical-Data-and-Initiation-of-Sale-of-THB335.html

GLOBENEWSWIRE
12 Jun 2025

https://www.globenewswire.com/news-release/2025/04/14/3060758/0/en/Third-Harmonic-Bio-Announces-Plan-of-Liquidation-and-Dissolution.html

GLOBENEWSWIRE
14 Apr 2025

https://www.globenewswire.com/news-release/2025/03/27/3050517/0/en/Third-Harmonic-Bio-Announces-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html

GLOBENEWSWIRE
27 Mar 2025

https://www.globenewswire.com/news-release/2025/02/11/3024041/0/en/Third-Harmonic-Bio-Announces-Phase-1-Clinical-Results-for-THB335-and-Provides-Corporate-Strategic-Update.html

GLOBENEWSWIRE
11 Feb 2025

https://www.globenewswire.com/news-release/2024/11/25/2987049/0/en/Third-Harmonic-Bio-to-Participate-in-the-7th-Annual-Evercore-HealthCONx-Conference.html

GLOBENEWSWIRE
25 Nov 2024

https://www.globenewswire.com/news-release/2024/11/07/2977064/0/en/Third-Harmonic-Bio-to-Participate-in-Upcoming-Investor-Conferences-in-November.html

GLOBENEWSWIRE
07 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty